<DOC>
	<DOC>NCT02244775</DOC>
	<brief_summary>The purpose of this study is to allow patients to undergo surgery with the SR™ MCP (Metacarpophalangeal) Implants for finger arthritis. This is NOT a research study, but rather, a requirement by the FDA for humanitarian use of device.</brief_summary>
	<brief_title>Use of Avanta Metacarpophalangeal (MCP) Joint Implant Finger Prosthesis, Humanitarian Use Device</brief_title>
	<detailed_description>The purpose of this IRB approved study is to allow patients to undergo surgery with the SR™ MCP (Metacarpophalangeal) Implants. This is NOT a research study, but rather, a requirement by the FDA for humanitarian use of device. Use of the SR™ MCP is approved for humanitarian use by the FDA when either the patient is in need of a revision of failed MCP prothesis(es) or the patient expects to place his/her hand under loading situation which preclude the use of an alternative implant in the painful osteo-arthritic and post traumatic arthritic MCP joint.</detailed_description>
	<criteria>patient is in need of a revision of failed MCP prosthesis(es) patient expects to place his/her hands under loading situations which preclude the use of an alternative implant in the painful osteoarthritic and post traumatic arthritic MCP joint patient is not in need of a revision of a failed MCP prothesis(es) patient is eligible to use an alternative implant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>osteo-arthritis</keyword>
	<keyword>post traumatic arthritis</keyword>
</DOC>